2026-06-30 The Top Presentations of EHA 2026 From Conference to Practice: Top 5 Takeaways From EHA 2026 Read More FDA Approves Gadoquatrane to Detect CNS and Non-CNS Body Region Lesions Read More NEW VIDEOExplore key insights from the 2026 ASCO Annual Meeting! Videos SC Mosunetuzumab Exhibits Response Durability in Follicular Lymphoma Watch Now Pirtobrutinib Regimen May Offer Prolonged Remissions in Pretreated CLL Watch Now Trending Elucidating First-Line SC Mosunetuzumab Benefit in Follicular Lymphoma Read More Givastomig Earns FDA Fast Track Designation in HER2-Negative Gastric Cancer Read More 回上一頁
